8. How Alliances Complete the Value Chain in Biotechnology and Pharmaceutical Business Models

  1. Constance Lütolf-Carroll,
  2. Antti Pirnes and
  3. Withers LLP
  1. Margaret Mullally

Published Online: 13 DEC 2011

DOI: 10.1002/9781118273166.ch8

From Innovation to Cash Flows: Value Creation by Structuring High Technology Alliances

From Innovation to Cash Flows: Value Creation by Structuring High Technology Alliances

How to Cite

Lütolf-Carroll, C., Antti Pirnes and Withers LLP (2009) How Alliances Complete the Value Chain in Biotechnology and Pharmaceutical Business Models, in From Innovation to Cash Flows: Value Creation by Structuring High Technology Alliances, John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9781118273166.ch8

Publication History

  1. Published Online: 13 DEC 2011
  2. Published Print: 13 JUL 2009

ISBN Information

Print ISBN: 9780470118092

Online ISBN: 9781118273166

SEARCH

Keywords:

  • biotechnology;
  • pharmaceutical business models;
  • research and development;
  • healthcare products;
  • entrepreneur

Summary

This chapter contains sections titled:

  • Risks and Uncertainty Associated with Drug Development

  • Value Chains in Pharmaceuticals and (Bio)Pharmaceuticals

  • Completion of the Biotechnology and Pharmaceutical Value Chain through Alliance Formation

  • Business Models in Pharmaceuticals and (Bio)Pharmaceuticals

  • Recent Trends and Emerging Business Models in Healthcare

  • Alliance Formation Crucial to Biotechnology and Pharmaceutical Business Models

  • Chapter Takeaways